November 21, 2024

From Barriers to Breakthrough: Effective Lung Cancer Early Detection Outreach

On November 13th, Eon hosted 28 clients for a virtual Peer Collaborative focused on lung cancer outreach. The session was co-moderated by Amie Miller from Sarasota Memorial Health System, who shared the successes and challenges her program has faced - even as it grew annual screening volumes by 26% from 2022 to 2023.

Despite national progress in the 5-year survival rate for lung cancer, leaders reported dealing with persistent challenges around physician buy-in, stigma, and patient education that contribute to the low up-take of lung cancer screening. A cross-cutting theme from the various conversations was the need for targeted outreach to meet specific sub-populations where they are. Below are three strategies attendees shared to increase screening uptake in key demographics.

About Eon

Eon is a healthcare technology company focused on supporting health systems in the identification and ongoing management of patients at risk of cancer and other lifethreatening conditions. Powered by condition-specific clinical AI, Eon’s longitudinal care management platform extracts incidental findings documented in radiology reports and helps ensure patients receive timely, guideline-based follow-up and remain in appropriate surveillance over time.

More than 70 health systems across over 1,200 facilities rely on Eon and its care management services to scale early detection programs, enable earlier diagnosis and treatment, and support sustained patient engagement—outcomes that also carry meaningful financial implications for health systems